Genitourinary system diseases

Within the category of diseases of the urogenital system, the G-BA includes diseases such as the urge to urinate as well as preparations for use following a kidney transplant. So far 11 different medicinal products have been assessed in 16 procedures. A major additional benefit has been displayed for 0%%, considerable additional benefit for 12.5% and minor additional benefit for 15.6% of the patient populations in question. A non-quantifiable additional benefit in relation to the comparative therapy has been proved for 6.3% of the subpopulations.

An additional benefit in relation to the comparative therapy has not been proved for 65.6% of the subpopulations as weighted according to their share of patients in the respective resolution. These subpopulations comprise 77% of the maximum of all 14.83 million patients suitable for treatment with the evaluated medicinal products who do not actually benefit from them.